Clinical trial NCT00681278: Retrospective Survey for Patients With Hypertension and Diabetes Mellitus
Official title: A Retrospective, Multi Centre, Non-interventional, Observational Study to Investigate Treatment Pattern of Blood Pressure in the Type II Diabetes Mellitus Patients With Hypertension.
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Hypertension
Keywords: Hypertension
Type II DM
JNC7
2007 ESH-ESC guidelines
survey
Lead sponsor: AstraZeneca
Sponsor class: INDUSTRY
First posted: 2008-05-21
Enrollment: 2000
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patient with type II Diabetes mellitus, receiving hypertension medication during at least 1 year.

Brief summary: This study will address the treatment rate and control rate of hypertension, treatment pattern and factors to affect blood pressure control by examining (retrospective) medical records of hypertension patients having Type 2 Diabetes mellitus, among outpatients coming to the Endocrinology Department in 20 general hospital settings nationwide.


Eligibility criteria: Inclusion Criteria:

* Outpatient Type II DM patients receiving hypertension medication in 2006
* Patient with Type II DM receiving hypertension medication during at least 1 year.

Exclusion Criteria:

* Secondary hypertension patients
* Patients not receiving hypertension medication

Primary outcomes:
measure: Attainment rate to the target blood pressure.
timeFrame: After collecting all Patient Record Form.
Secondary outcomes:
measure: Dropout rate will be estimated during the follow-up period after the hypertension treatment. Attainment to the target blood pressure will be investigated according to concomitant diseases.
timeFrame: After collecting all Patient Record Form.
measure: Change in DBP/SBP value during the follow-up period will be addressed. Change in the DBP/SBP value will be investigated according to the risk factors and concurrent disease.
timeFrame: After collecting all Patient Record Form.
Other outcomes:
Locations:
city: Bucheon
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Goyang
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Guri
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Sungnam
country: Korea, Republic of
facility: Research Site
state: Gyeonggi
city: Jeonju
country: Korea, Republic of
facility: Research Site
state: Keollabuk
city: Busan
country: Korea, Republic of
facility: Research Site
city: Deagu
country: Korea, Republic of
facility: Research Site
city: Deajeon
country: Korea, Republic of
facility: Research Site
city: Incheon
country: Korea, Republic of
facility: Research Site
city: Kwangju
country: Korea, Republic of
facility: Research Site
city: Seoul
country: Korea, Republic of
facility: Research Site
city: Suwon
country: Korea, Republic of
facility: Research Site
city: Wonju
country: Korea, Republic of
facility: Research Site
Study officials:
affiliation: Astrazenca Korea medical dept,.
name: Joon Woo Bahn
role: STUDY_DIRECTOR
References: